Piper Jaffray Reiterates Overweight on SYK

Piper Jaffray has issued a report reiterating an Overweight Rating on Stryker Corp SYK. According to the report, "Strength across almost every business line drove upside to our Q2 revenue and EPS estimates, partially boosted by FX but principally led by very strong US Medical revenues (+$30 mil) driven by another quarter of robust hospital capital spending." SYK has a $72 Price Target and closed yesterday at $59.16 a share.